background
pcr
coupl
electrospray
ioniz
mass
spectrometri
technolog
pcresitofm
plexid
system
abbott
ibi
bioscienc
develop
character
microbi
pathogen
object
evalu
perform
plexid
flu
detect
tm
kit
detect
influenza
virus
comparison
multiplex
respifind
kit
pathofind
studi
design
acutephas
respiratori
sampl
n
analys
purpos
subpopul
influenza
type
posit
sampl
identifi
respifind
kit
n
subtyp
realtim
readi
inf
detect
set
roch
molecular
diagnost
result
compar
plexid
flu
detect
tm
kit
result
sampl
gave
concord
result
p
influenza
aposit
influenza
bposit
neg
sampl
sampl
plexid
positiverespifind
neg
influenza
influenza
b
plexid
positiverespifind
neg
influenza
influenza
b
plexid
show
one
sampl
influenza
b
coinfect
respifind
assay
show
influenza
aposit
sensit
specif
posit
neg
predict
valu
plexid
tm
system
respect
thirteen
discord
sampl
avail
retest
investig
anyplex
tm
ii
detect
kit
seegen
seven
respifind
concord
six
plexid
tm
concord
subtyp
influenza
sampl
concord
six
three
sampl
gave
neg
plexid
tm
result
one
two
conclus
pcresitofm
technolog
show
good
diagnost
perform
detect
subtyp
influenza
virus
influenza
virus
respons
winter
epidem
among
children
adult
huge
potenti
cost
societi
influenza
virus
detect
directli
respiratori
sampl
origin
done
use
cell
cultur
direct
antigen
detect
culturebas
method
timeconsum
direct
antigen
detect
sensit
enough
provid
reliabl
diagnosi
molecular
diagnost
global
current
standard
technolog
overcom
limit
major
molecular
approach
influenza
virus
detect
base
upon
realtim
reversetranscript
pcr
target
segment
encod
conserv
matrix
protein
gene
segment
downstream
assay
use
type
influenza
b
subtyp
influenza
influenza
subtyp
avian
detect
use
current
molecular
techniqu
target
hemagglutinin
ha
neuraminidas
na
howev
still
difficult
detect
identifi
emerg
virus
reassort
intern
gene
new
technolog
like
polymeras
chain
reaction
pcr
electrospray
ioniz
timeofflight
mass
spectrometri
pcresitofm
abl
identifi
pathogen
method
origin
appli
microbiolog
identifi
speci
bacteria
respiratori
sampl
also
use
identifi
virus
includ
coronaviru
adenoviru
pcresitofm
technolog
recent
use
identifi
character
recombin
influenza
identifi
origin
gene
segment
reassort
viru
porcin
human
avian
influenza
virus
techniqu
also
independ
evalu
abil
type
influenza
retrospect
nasopharyng
specimen
present
studi
first
show
result
sampl
collect
prospect
compar
multiplex
refer
method
differ
previous
publish
method
studi
evalu
suitabl
plexid
flu
detect
tm
assay
base
upon
reversetranscript
rt
coupl
pcresitofm
detect
influenza
virus
prospect
clinic
respiratori
sampl
determin
subtyp
sampl
test
multiplex
respifind
kit
use
refer
comparison
discrep
result
test
third
rtpcr
multiplex
molecular
techniqu
confirm
result
discrimin
influenza
subtyp
subpopul
sampl
influenza
posit
respifind
kit
use
realtim
readi
inf
detect
set
result
compar
obtain
plexid
flu
detect
assay
depart
virolog
chu
toulous
franc
test
respiratori
sampl
prospect
collect
winter
season
flu
epidem
peak
french
flu
survey
network
collect
children
attend
pediatr
unit
toulous
univers
hospit
nasopharyng
swab
sampl
collect
virocult
swab
kitvia
labarth
inard
franc
store
c
respiratori
sampl
test
prospect
mlpa
total
nucleic
acid
extract
magna
pure
lc
total
nucleic
kit
roch
magna
pure
lc
tm
instrument
accord
manufactur
instruct
input
sampl
volum
l
output
elut
volum
l
concentr
respiratori
virus
detect
respifind
dc
kit
detect
respiratori
virus
influenza
viru
type
influenza
viru
type
b
avian
influenza
viru
respiratori
syncyti
virus
rsv
b
parainfluenza
virus
coronavirus
rhinoviru
adenoviru
human
metapneumoviru
method
base
amplifi
viral
genom
multiplex
rtpcr
sensit
due
hybrid
ligat
pcr
probe
variou
amplicon
detect
sizefraction
capillari
electrophoresi
system
sequenc
analyz
abi
xl
appli
biosystem
intern
amplif
control
rna
transcript
encephalomyocard
emc
viru
check
presenc
sampl
addit
absenc
pcr
inhibitor
mlpa
test
differenti
influenza
influenza
virus
influenza
type
virus
detect
subtyp
test
influenza
posit
magna
pure
total
nucleic
acid
extract
realtim
readi
inf
detect
set
roch
diagnost
employ
rna
viru
master
onestep
rtpcr
kit
roch
diagnost
accord
manufactur
instruct
light
cycler
tm
system
roch
diagnost
meylan
franc
set
contain
specif
primerprob
mix
detect
influenza
matrix
protein
hemagglutinin
singl
reaction
respiratori
sampl
analyz
plexid
system
abbott
molecular
il
usa
rna
extract
nasopharyng
swab
use
plexid
viral
rna
isol
kit
abbott
molecular
il
usa
plexid
fh
sp
instrument
fulli
autom
manner
input
sampl
volum
l
output
elut
volum
l
concentr
plexid
fluid
handler
use
distribut
nucleic
acid
enzym
pcr
plexid
flu
detect
plate
viral
nucleic
acid
amplifi
use
plexid
flu
detect
tm
kit
abbott
molecular
il
usa
segment
influenza
genom
amplifi
pcr
plexid
tc
mastercycl
proseppendorf
use
nine
primerpair
locat
core
conserv
site
region
target
shown
tabl
primerpair
detect
influenza
virus
b
c
type
primerpair
target
nucleoprotein
np
matrix
protein
polymeras
pa
nonstructur
polymeras
basic
protein
gene
segment
design
amplifi
sequenc
influenza
virus
primerpair
locat
ha
na
glycoprotein
design
amplifi
influenza
specif
primer
select
amplifi
influenza
b
addit
paninfluenza
primer
last
well
contain
influenza
ana
cover
common
mutat
associ
oseltamivir
tamiflu
resist
amplicon
automat
desalt
purifi
weak
anion
exchang
methanolbas
aerosol
contain
denatur
ioniz
amplicon
spray
mass
spectromet
timeofflight
detector
determin
give
mass
amplicon
databas
analysi
base
composit
bc
pcr
amplicon
deriv
viral
gene
segment
determin
influenza
virus
type
subtyp
bioinformat
analysi
bc
signatur
produc
nine
target
gene
bc
signatur
compar
known
bc
signatur
refer
databas
influenza
research
databas
ncbi
influenza
viru
resourc
system
influenzaorg
virus
identifi
match
closest
signatur
databas
anyplex
tm
ii
detect
kit
seegen
use
third
analyt
techniqu
sampl
gave
discord
result
multiplex
rtpcr
test
detect
virus
includ
influenza
b
data
analyz
use
statview
statatm
softwar
statacorp
texa
kappacohen
test
use
compar
assay
p
valu
less
consid
signific
sensit
percentag
reactiv
sampl
assay
compar
use
mcnemar
chisquar
test
tabl
locat
sequenc
nine
primerpair
well
employ
amplif
identif
influenza
viru
gene
segment
electrospray
ioniz
mass
spectrometri
respiratori
sampl
collect
femal
male
mean
age
median
rang
month
year
mean
age
french
flu
survey
network
year
median
year
mean
age
collect
children
attend
pediatr
unit
toulous
univers
hospit
year
median
year
plexid
tm
respifind
refer
assay
gave
discrep
result
sampl
plexid
tm
posit
respifind
neg
influenza
three
one
one
influenza
viru
three
sampl
posit
rsv
respifind
dc
kit
assay
collect
children
attend
emerg
unit
twelv
sampl
plex
id
tm
neg
respifind
posit
ten
sampl
influenza
posit
two
influenza
b
posit
determin
subtyp
sampl
test
posit
influenza
virus
respifind
use
realtim
readi
inf
detect
set
roch
molecular
diagnosi
sampl
eight
influenza
virus
compar
result
obtain
plexid
tm
flu
detect
assay
tabl
found
sampl
gave
concord
result
virus
ie
flu
respifind
assay
three
sampl
gave
neg
plexid
tm
result
one
sampl
two
influenza
virus
thirteen
discord
sampl
test
anyplex
tm
ii
detect
kit
seven
respifind
concord
six
plexid
tm
concord
tabl
six
discord
sampl
test
due
lack
materi
studi
report
evalu
plexid
technolog
detect
identifi
influenza
genom
clinic
sampl
plexid
tm
flu
detect
kit
plexid
tm
analyz
emerg
reassort
influenza
virus
due
accumul
mutat
h
n
gene
may
lead
appear
new
virus
may
spread
throughout
whole
human
popul
case
viru
tripl
reassort
porcin
acquir
gene
human
influenza
viru
sequenc
porcin
origin
discov
pcr
coupl
electrospray
ioniz
timeofflight
mass
spectrometri
suitabl
sensit
pcresitofm
technolog
use
clinic
diagnosi
yet
determin
therefor
evalu
suitabl
new
techniqu
detect
subtyp
influenza
genom
prospect
clinic
sampl
refer
techniqu
wide
use
respifind
dc
commerci
kit
detect
respiratori
virus
includ
influenza
b
avian
viru
kit
identifi
use
group
sampl
influenza
posit
distinguish
virus
use
realtim
readi
inf
detect
set
assay
respifind
plexid
tm
flu
detect
assay
perform
compar
gave
similar
result
sampl
gave
discrep
result
test
third
confirmatori
techniqu
result
seven
referenceconfirmatori
assay
posit
six
plexidconfirmatori
assay
posit
could
attribut
intermitt
stochast
posit
lower
limit
detect
methodolog
low
titr
sampl
confirm
high
cross
point
valu
ct
obtain
confirmatori
techniqu
cycl
plexid
tm
flu
detect
assay
detect
influenza
influenza
b
genom
also
distinguish
respifind
techniqu
detect
influenza
genom
three
sampl
posit
rsv
primer
compet
virus
present
minor
quantiti
clinic
sampl
may
amplifi
plexid
tm
system
suffer
restrict
employ
multipl
primerpair
target
core
region
virus
monoplex
endpoint
rtpcr
plexid
platform
evalu
complet
system
includ
extract
pcr
analysi
plexid
tm
analyz
pcr
analysi
twice
fast
ibi
ibi
bioscienc
inc
carlsbad
ca
usa
first
platform
use
pcresitofm
technolog
plexid
tm
input
stacker
take
plate
pcr
platform
process
approxim
sampl
per
new
kit
use
studi
also
identifi
virus
previou
one
could
influenza
virus
identifi
subtyp
bioinformat
analysi
detect
amplicon
signatur
refer
regularli
updat
databas
contain
refer
bc
signatur
mean
genotyp
influenza
genom
may
recognis
diagnos
well
new
zanamivir
antivir
resist
mutat
newli
emerg
swine
variant
v
openmod
refer
databas
system
easili
access
would
great
help
would
enabl
detect
chang
viru
winter
season
new
signatur
could
ad
keep
databas
uptod
conclus
result
obtain
clinic
sampl
collect
prospect
show
assay
detect
identifi
influenza
b
genom
well
coinfect
two
virus
also
success
subtyp
influenza
genom
assay
result
well
correl
obtain
refer
method
show
primerpair
design
base
core
conserv
region
viru
genom
suitabl
identifi
character
influenza
virus
plexid
flu
detect
tm
kit
provid
abbott
ibi
bioscienc
